Use of adipose-derived mesenchymal stem cells in keratoconjunctivitis sicca in a canine model

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Villatoro, Antonio J ^a   Fernández, Viviana ^a   Claros, Silvia ^a,b   Rico Llanos, Gustavo A ^a,b,c   Becerra, José ^a,b,c   Andrades, José A ^a,b  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b Biomaterials and Nanomedicine   (Spain)

^c Institute of Biomedical Research in Malaga and BIONAND Nanomedicine Platform   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL TEAR; CORTICOSTEROID; CYCLOSPORIN; TACROLIMUS;

ADIPOSE DERIVED MESENCHYMAL STROMAL CELL TRANSPLANTATION; ADIPOSE DERIVED STEM CELL; ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANINE MODEL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONJUNCTIVAL HYPEREMIA; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOG BREED; EXPERIMENTAL OCULAR INFLAMMATION; FEMALE; FOLLOW UP; KERATOCONJUNCTIVITIS SICCA; LACRIMAL GLAND; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIMARY CELL CULTURE; SCHIRMER TEST; SURFACE PROPERTY; THERAPY EFFECT; ADIPOSE TISSUE; ANIMAL; CELL CULTURE; CELL LINEAGE; CELL SEPARATION; CELL SHAPE; CYTOLOGY; DISEASE MODEL; DOG; EYE; FLOW CYTOMETRY; HUMAN; MESENCHYMAL STROMA CELL; PATHOLOGY;

ANIMALIA; CANIS FAMILIARIS;

ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SEPARATION; CELL SHAPE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOGS; EYE; FEMALE; FLOW CYTOMETRY; HUMANS; KERATOCONJUNCTIVITIS SICCA; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS;

EID: 84924587855     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/527926     Document Type: Article

References (84)

1. N. Gupta, I. Prasad, G. Himashree, and P. D'Souza, "Prevalence of dry eye at high altitude: a case controlled comparative study," High Altitude Medicine and Biology, Vol. 9, no. 4, pp. 327-334, 2008.
2. J. A. Smith, J. Albenz, C. Begley et al., "The epidemiology of dry eye disease: report of the epidemiology subcommittee of the international Dry Eye WorkShop (2007)," Ocular Surface, Vol. 5, no. 2, pp. 93-107, 2007.
3. M. B. Abelson, G. W. Ousler III, and C. Maffei, "Dry eye in 2008," Current Opinion in Ophthalmology, Vol. 20, no. 4, pp. 282-286, 2009.
4. S. Barabino and M. R. Dana, "Animal models of dry eye: a critical assessment of opportunities and limitations," Investigative Ophthalmology and Visual Science, Vol. 45, no. 6, pp. 1641-1646, 2004.
5. W. Stevenson, S. K. Chauhan, and R. Dana, "Dry eye disease: an immune-mediated ocular surface disorder," Archives of Ophthalmology, Vol. 130, no. 1, pp. 90-100, 2012.
6. D. L. Williams, "Immunopathogenesis of Keratoconjunctivitis sicca in the dog," Veterinary Clinics of North America: Small Animal Practice, Vol. 38, no. 2, pp. 251-268, 2008.
7. A. A. Worster, A. J. Nixon, B. D. Brower-Toland, and J. Williams, "Effect of transforming growth factor β1 on chondrogenic differentiation of cultured equine mesenchymal stem cells," American Journal of Veterinary Research, Vol. 61, no. 9, pp. 1003-1010, 2000.
8. M. A. Lemp, "Management of dry eye disease," The American Journal of Managed Care, Vol. 14, no. 3, pp. S88-S101, 2008.
9. M. B. Murphy, K. Moncivais, and A. I. Caplan, "Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine," Experimental and Molecular Medicine, Vol. 45, no. 11, article e54, 2013.
10. S. K. Kapur and A. J. Katz, "Review of the adipose derived stem cell secretome," Biochimie, Vol. 95, no. 12, pp. 2222-2228, 2013.
11. J. W. Kang, K.-S. Kang, H. C. Koo, J. R. Park, E. W. Choi, and Y. H. Park, "Soluble factors-mediated immunomodulatory effects of canine adipose tissue-derived mesenchymal stem cells," Stem Cells and Development, Vol. 17, no. 4, pp. 681-693, 2008.
12. D. D. Carrade, V. K. Affolter, C. A. Outerbridge et al., "Intradermal injections of equine allogeneic umbilical cord-derived mesenchymal stem cells are well tolerated and do not elicit immediate or delayed hypersensitivity reactions," Cytotherapy, Vol. 13, no. 10, pp. 1180-1192, 2011.
13. M. Alonso, S. Claros, J. Becerra, and J. A. Andrades, "The effect of type I collagen on osteochondrogenic differentiation in adipose-derived stromal cells in vivo," Cytotherapy, Vol. 10, no. 6, pp. 597-610, 2008.
14. H. Yagi, A. Soto-Gutierrez, B. Parekkadan et al., "Mesenchymal stem cells: mechanisms of immunomodulation and homing," Cell Transplantation, Vol. 19, no. 6-7, pp. 667-679, 2010.
15. A. A. Leto Barone, S. Khalifian, W. P. A. Lee, and G. Brandacher, "Immunomodulatory effects of adipose-derived stem cells: fact or fiction?" BioMed Research International, Vol. 2013, Article ID 383685, 8 pages, 2013.
16. E. de Bakker, B. van Ryssen, C. de Schauwer, and E. Meyer, "Canine mesenchymal stem cells: state of the art, perspectives as therapy for dogs and as a model for man," Veterinary Quarterly, Vol. 33, no. 4, pp. 225-233, 2013.
17. F. W. Quimby, R. S. Schwartz, T. Poskitt, and R. M. Lewis, "A disorder of dogs resembling Sjögren's syndrome," Clinical Immunology and Immunopathology, Vol. 12, no. 4, pp. 471-476, 1979.
18. R. E. Hamor, S. M. Roberts, G. A. Severin, and M. J. Chavkin, "Evaluation of results for Schirmer tear tests conducted with and without application of a topical anesthetic in clinically normal dogs of 5 breeds," American Journal of Veterinary Research, Vol. 61, no. 11, pp. 1422-1425, 2000.
19. D. Dursun, M. Wang, D. Monroy et al., "A mouse model of keratoconjunctivitis sicca," Investigative Ophthalmolog y & Visual Science, Vol. 43, no. 3, pp. 632-638, 2002.
20. D. Zoukhri, "Mechanisms involved in injury and repair of the murine lacrimal gland: role of programmed cell death and mesenchymal stem cells," Ocular Surface, Vol. 8, no. 2, pp. 60-69, 2010.
21. M. L. Massingale, X. Li, M. Vallabhajosyula, D. Chen, Y. Wei, and P. A. Asbell, "Analysis of inflammatory cytokines in the tears of dry eye patients," Cornea, Vol. 28, no. 9, pp. 1023-1027, 2009.
22. X. Q. Zhou and R. L. Wei, "Topical cyclosporine a in the treatment of dry eye: a systematic review and meta-analysis," Cornea, Vol. 33, no. 7, pp. 760-767, 2014.
23. L. Barachetti, A. Rampazzo, C. M. Mortellaro, S. Scevola, and B. C. Gilger, "Use of episcleral cyclosporine implants in dogs with keratoconjunctivitis sicca: pilot study," Veterinary Ophthalmology, 2014.
24. E. M. Schuh, M. S. Friedman, D. D. Carrade et al., "Identification of variables that optimize isolation and culture of multipotent mesenchymal stem cells from equine umbilical-cord blood," American Journal of Veterinary Research, Vol. 70, no. 12, pp. 1526-1535, 2009.
25. N. M. Vieira, V. Brandalise, E. Zucconi, M. Secco, B. E. Strauss, and M. Zatz, "Isolation, characterization, and differentiation potential of canine adipose-derived stem cells," Cell Transplantation, Vol. 19, no. 3, pp. 279-289, 2010.
26. D. J. Chung, K. Hayashi, C. A. Toupadakis, A. Wong, and C. E. Yellowley, "Osteogenic proliferation and differentiation of canine bone marrow and adipose tissue derived mesenchymal stromal cells and the influence of hypoxia," Research in Veterinary Science, Vol. 92, no. 1, pp. 66-75, 2012.
27. T. Martinello, I. Bronzini, L. Maccatrozzo et al., "Canine adipose-derived-mesenchymal stem cells do not lose stem features after a long-term cryopreservation," Research in Veterinary Science, Vol. 91, no. 1, pp. 18-24, 2011.
28. K. Bharti, M. Rao, S. C. Hull et al., "Developing cellular therapies for retinal degenerative diseases," Investigative Ophthalmolog y & Visual Science, Vol. 55, no. 2, pp. 1191-1201, 2014.
29. V. Holan and E. Javorkova, "Mesenchymal stem cells, nanofiber scaffolds and ocular surface reconstruction," Stem Cell Reviews and Reports, Vol. 9, no. 5, pp. 609-619, 2013.
30. A. Yamada, T. Yokoo, S. Yokote et al., "Comparison of multipo-tency and molecular profile of MSCs between CKD and healthy rats," Human Cell, Vol. 27, no. 2, pp. 59-67, 2014.
31. A. Efimenko, N. Dzhoyashvili, N. Kalinina et al., "Adipose-derived mesenchymal stromal cells from aged patients with coronary artery disease keep mesenchymal stromal cell properties but exhibit characteristics of aging and have impaired angiogenic potential," Stem Cells Translational Medicine, Vol. 3, no. 1, pp. 32-41, 2014.
32. W. Wu, L. Niklason, and D. M. Steinbacher, "The effect of age on human adipose-derived stem cells," Plastic and Reconstructive Surgery, Vol. 131, no. 1, pp. 27-37, 2013.
33. A. Guercio, S. D. Bella, S. Casella, P. D. Marco, C. Russo, and G. Piccione, "Canine mesenchymal stem cells (MSCs): characterization in relation to donor age and adipose tissue-harvesting site," Cell Biology International, Vol. 37, no. 8, pp. 789-798, 2013.
34. J. A. Wood, D. J. Chung, S. A. Park et al., "Periocular and intra-articular injection of canine adipose-derived mesenchymal stem cells: An in vivo imaging and migration study," Journal of Ocular Pharmacology and Therapeutics, Vol. 28, no. 3, pp. 307-317, 2012.
35. H. Takemitsu, D. Zhao, S. Ishikawa, M. Michishita, T. Arai, and I. Yamamoto, "Mechanism of insulin production in canine bone marrow derived mesenchymal stem cells," General and Comparative Endocrinology, Vol. 189, pp. 1-6, 2013.
36. M. Dominici, K. Le Blanc, I. Mueller et al., "Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement," Cytotherapy, Vol. 8, no. 4, pp. 315-317, 2006.
37. H. M. Hodgkiss-Geere, D. J. Argyle, B. M. Corcoran et al., "Characterisation and differentiation potential of bone marrow derived canine mesenchymal stem cells," Veterinary Journal, Vol. 194, no. 3, pp. 361-368, 2012.
38. J. E. Dennis, J.-P. Carbillet, A. I. Caplan, and P. Charbord, "The STRO-1+ marrow cell population is multipotential," Cells Tissues Organs, Vol. 170, no. 2-3, pp. 73-82, 2002.
39. S. Redaelli, A. Bentivegna, D. Foudah et al., "From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells," Stem Cell Research and Therapy, Vol. 3, no. 6, article 47, 2012.
40. R. Binato, T. de Souza Fernandez, C. Lazzarotto-Silva et al., "Stability of human mesenchymal stem cells during in vitro culture: considerations for cell therapy," Cell Proliferation, Vol. 46, no. 1, pp. 10-22, 2013.
41. J. Xu, D. Wang, D. Liu et al., "Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome," Blood, Vol. 120, no. 15, pp. 3142-3151, 2012.
42. G. N. Foulks and S. C. Pflugfelder, "New testing options for diagnosing and grading dry eye disease," American Journal of Ophthalmology, Vol. 157, no. 6, pp. 1122-1129, 2014.
43. N. Gupta, I. Prasad, G. Himashree, and P. D'Souza, "Prevalence of dry eye at high altitude: a case controlled comparative study," High Altitude Medicine and Biology, Vol. 9, no. 4, pp. 327-334, 2008.
44. J. A. Smith, J. Albenz, C. Begley et al., "The epidemiology of dry eye disease: report of the epidemiology subcommittee of the international Dry Eye WorkShop (2007)," Ocular Surface, Vol. 5, no. 2, pp. 93-107, 2007.
45. M. B. Abelson, G. W. Ousler III, and C. Maffei, "Dry eye in 2008," Current Opinion in Ophthalmology, Vol. 20, no. 4, pp. 282-286, 2009.
46. S. Barabino and M. R. Dana, "Animal models of dry eye: a critical assessment of opportunities and limitations," Investigative Ophthalmology and Visual Science, Vol. 45, no. 6, pp. 1641-1646, 2004.
47. W. Stevenson, S. K. Chauhan, and R. Dana, "Dry eye disease: an immune-mediated ocular surface disorder," Archives of Ophthalmology, Vol. 130, no. 1, pp. 90-100, 2012.
48. D. L. Williams, "Immunopathogenesis of Keratoconjunctivitis sicca in the dog," Veterinary Clinics of North America: Small Animal Practice, Vol. 38, no. 2, pp. 251-268, 2008.
49. A. A. Worster, A. J. Nixon, B. D. Brower-Toland, and J. Williams, "Effect of transforming growth factor β1 on chondrogenic differentiation of cultured equine mesenchymal stem cells," American Journal of Veterinary Research, Vol. 61, no. 9, pp. 1003-1010, 2000.
50. M. A. Lemp, "Management of dry eye disease," The American Journal of Managed Care, Vol. 14, no. 3, pp. S88-S101, 2008.
51. M. B. Murphy, K. Moncivais, and A. I. Caplan, "Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine," Experimental and Molecular Medicine, Vol. 45, no. 11, article e54, 2013.
52. S. K. Kapur and A. J. Katz, "Review of the adipose derived stem cell secretome," Biochimie, Vol. 95, no. 12, pp. 2222-2228, 2013.
53. J. W. Kang, K.-S. Kang, H. C. Koo, J. R. Park, E. W. Choi, and Y. H. Park, "Soluble factors-mediated immunomodulatory effects of canine adipose tissue-derived mesenchymal stem cells," Stem Cells and Development, Vol. 17, no. 4, pp. 681-693, 2008.
54. D. D. Carrade, V. K. Affolter, C. A. Outerbridge et al., "Intradermal injections of equine allogeneic umbilical cord-derived mesenchymal stem cells are well tolerated and do not elicit immediate or delayed hypersensitivity reactions," Cytotherapy, Vol. 13, no. 10, pp. 1180-1192, 2011.
55. M. Alonso, S. Claros, J. Becerra, and J. A. Andrades, "The effect of type I collagen on osteochondrogenic differentiation in adipose-derived stromal cells in vivo," Cytotherapy, Vol. 10, no. 6, pp. 597-610, 2008.
56. H. Yagi, A. Soto-Gutierrez, B. Parekkadan et al., "Mesenchymal stem cells: mechanisms of immunomodulation and homing," Cell Transplantation, Vol. 19, no. 6-7, pp. 667-679, 2010.
57. A. A. Leto Barone, S. Khalifian, W. P. A. Lee, and G. Brandacher, "Immunomodulatory effects of adipose-derived stem cells: fact or fiction?" BioMed Research International, Vol. 2013, Article ID 383685, 8 pages, 2013.
58. E. de Bakker, B. van Ryssen, C. de Schauwer, and E. Meyer, "Canine mesenchymal stem cells: state of the art, perspectives as therapy for dogs and as a model for man," Veterinary Quarterly, Vol. 33, no. 4, pp. 225-233, 2013.
59. F. W. Quimby, R. S. Schwartz, T. Poskitt, and R. M. Lewis, "A disorder of dogs resembling Sjögren's syndrome," Clinical Immunology and Immunopathology, Vol. 12, no. 4, pp. 471-476, 1979.
60. R. E. Hamor, S. M. Roberts, G. A. Severin, and M. J. Chavkin, "Evaluation of results for Schirmer tear tests conducted with and without application of a topical anesthetic in clinically normal dogs of 5 breeds," American Journal of Veterinary Research, Vol. 61, no. 11, pp. 1422-1425, 2000.
61. D. Dursun, M. Wang, D. Monroy et al., "A mouse model of keratoconjunctivitis sicca," Investigative Ophthalmolog y & Visual Science, Vol. 43, no. 3, pp. 632-638, 2002.
62. D. Zoukhri, "Mechanisms involved in injury and repair of the murine lacrimal gland: role of programmed cell death and mesenchymal stem cells," Ocular Surface, Vol. 8, no. 2, pp. 60-69, 2010.
63. M. L. Massingale, X. Li, M. Vallabhajosyula, D. Chen, Y. Wei, and P. A. Asbell, "Analysis of inflammatory cytokines in the tears of dry eye patients," Cornea, Vol. 28, no. 9, pp. 1023-1027, 2009.
64. X. Q. Zhou and R. L. Wei, "Topical cyclosporine a in the treatment of dry eye: a systematic review and meta-analysis," Cornea, Vol. 33, no. 7, pp. 760-767, 2014.
65. L. Barachetti, A. Rampazzo, C. M. Mortellaro, S. Scevola, and B. C. Gilger, "Use of episcleral cyclosporine implants in dogs with keratoconjunctivitis sicca: pilot study," Veterinary Ophthalmology, 2014.
66. E. M. Schuh, M. S. Friedman, D. D. Carrade et al., "Identification of variables that optimize isolation and culture of multipotent mesenchymal stem cells from equine umbilical-cord blood," American Journal of Veterinary Research, Vol. 70, no. 12, pp. 1526-1535, 2009.
67. N. M. Vieira, V. Brandalise, E. Zucconi, M. Secco, B. E. Strauss, and M. Zatz, "Isolation, characterization, and differentiation potential of canine adipose-derived stem cells," Cell Transplantation, Vol. 19, no. 3, pp. 279-289, 2010.
68. D. J. Chung, K. Hayashi, C. A. Toupadakis, A. Wong, and C. E. Yellowley, "Osteogenic proliferation and differentiation of canine bone marrow and adipose tissue derived mesenchymal stromal cells and the influence of hypoxia," Research in Veterinary Science, Vol. 92, no. 1, pp. 66-75, 2012.
69. T. Martinello, I. Bronzini, L. Maccatrozzo et al., "Canine adipose-derived-mesenchymal stem cells do not lose stem features after a long-term cryopreservation," Research in Veterinary Science, Vol. 91, no. 1, pp. 18-24, 2011.
70. K. Bharti, M. Rao, S. C. Hull et al., "Developing cellular therapies for retinal degenerative diseases," Investigative Ophthalmolog y & Visual Science, Vol. 55, no. 2, pp. 1191-1201, 2014.
71. V. Holan and E. Javorkova, "Mesenchymal stem cells, nanofiber scaffolds and ocular surface reconstruction," Stem Cell Reviews and Reports, Vol. 9, no. 5, pp. 609-619, 2013.
72. A. Yamada, T. Yokoo, S. Yokote et al., "Comparison of multipo-tency and molecular profile of MSCs between CKD and healthy rats," Human Cell, Vol. 27, no. 2, pp. 59-67, 2014.
73. A. Efimenko, N. Dzhoyashvili, N. Kalinina et al., "Adipose-derived mesenchymal stromal cells from aged patients with coronary artery disease keep mesenchymal stromal cell properties but exhibit characteristics of aging and have impaired angiogenic potential," Stem Cells Translational Medicine, Vol. 3, no. 1, pp. 32-41, 2014.
74. W. Wu, L. Niklason, and D. M. Steinbacher, "The effect of age on human adipose-derived stem cells," Plastic and Reconstructive Surgery, Vol. 131, no. 1, pp. 27-37, 2013.
75. A. Guercio, S. D. Bella, S. Casella, P. D. Marco, C. Russo, and G. Piccione, "Canine mesenchymal stem cells (MSCs): characterization in relation to donor age and adipose tissue-harvesting site," Cell Biology International, Vol. 37, no. 8, pp. 789-798, 2013.
76. J. A. Wood, D. J. Chung, S. A. Park et al., "Periocular and intra-articular injection of canine adipose-derived mesenchymal stem cells: An in vivo imaging and migration study," Journal of Ocular Pharmacology and Therapeutics, Vol. 28, no. 3, pp. 307-317, 2012.
77. H. Takemitsu, D. Zhao, S. Ishikawa, M. Michishita, T. Arai, and I. Yamamoto, "Mechanism of insulin production in canine bone marrow derived mesenchymal stem cells," General and Comparative Endocrinology, Vol. 189, pp. 1-6, 2013.
78. M. Dominici, K. Le Blanc, I. Mueller et al., "Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement," Cytotherapy, Vol. 8, no. 4, pp. 315-317, 2006.
79. H. M. Hodgkiss-Geere, D. J. Argyle, B. M. Corcoran et al., "Characterisation and differentiation potential of bone marrow derived canine mesenchymal stem cells," Veterinary Journal, Vol. 194, no. 3, pp. 361-368, 2012.
80. J. E. Dennis, J.-P. Carbillet, A. I. Caplan, and P. Charbord, "The STRO-1+ marrow cell population is multipotential," Cells Tissues Organs, Vol. 170, no. 2-3, pp. 73-82, 2002.
81. S. Redaelli, A. Bentivegna, D. Foudah et al., "From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells," Stem Cell Research and Therapy, Vol. 3, no. 6, article 47, 2012.
82. R. Binato, T. de Souza Fernandez, C. Lazzarotto-Silva et al., "Stability of human mesenchymal stem cells during in vitro culture: considerations for cell therapy," Cell Proliferation, Vol. 46, no. 1, pp. 10-22, 2013.
83. J. Xu, D. Wang, D. Liu et al., "Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome," Blood, Vol. 120, no. 15, pp. 3142-3151, 2012.
84. G. N. Foulks and S. C. Pflugfelder, "New testing options for diagnosing and grading dry eye disease," American Journal of Ophthalmology, Vol. 157, no. 6, pp. 1122-1129, 2014.